Lipid Nanocarriers of a Lipid-Conjugated Estrogenic Derivative Inhibit Tumor Growth and Enhance Cisplatin Activity against Triple-Negative Breast Cancer: Pharmacokinetic and Efficacy Evaluation-Reference-Cited by-同舟云学术

Lipid Nanocarriers of a Lipid-Conjugated Estrogenic Derivative Inhibit Tumor Growth and Enhance Cisplatin Activity against Triple-Negative Breast Cancer: Pharmacokinetic and Efficacy Evaluation

Published:2015-03-02 Issue:4 Volume:12 Page:1105-1120
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Andey Terrick¹,Sudhakar Godeshala²,Marepally Srujan³,Patel Apurva⁴,Banerjee Rajkumar²,Singh Mandip⁴

Affiliation:

1. Department of Pharmaceutical Sciences, School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, 19 Foster Street, Worcester, Massachusetts 01608, United States

2. Biomaterials Group, CSIR-Indian Institute of Chemical Technology, Uppal Road, Hyderabad, Andhra Pradesh 500007, India

3. Institute for Stem Cell Biology and Regenerative Medicine (inStem), NCBS-TIFR, UAS-GKVK, Bengaluru, Karnataka 560067, India

4. Department of Pharmaceutics, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, 1520 South Martin Luther King Jr. Boulevard, Tallahassee, Florida 32307, United States

Funder

U.S. Department of Defense

National Institute of General Medical Sciences

National Institute on Minority Health and Health Disparities

Department of Science and Technology, Ministry of Science and Technology

Council of Scientific and Industrial Research

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp5008629

Reference55 articles.

1. Prospective identification of tumorigenic breast cancer cells

2. Comprehensive molecular portraits of human breast tumours

3. American Cancer Society. Cancer Facts & Figures 2014.http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/index(accessed September 2, 2014).

4. Cancer statistics, 2013

5. Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Strategies Using Sagacious Targeting for Site-Specific Drug Delivery in Breast Cancer Treatment: Clinical Potential and Applications;Critical Reviews™ in Therapeutic Drug Carrier Systems;2024

2. Advancement in Biopolymer Assisted Cancer Theranostics;ACS Applied Bio Materials;2023-09-12

3. Theranostics of triple negative breast cancer: a review;Diagnostic radiology and radiotherapy;2023-07-05

4. A review of nanomaterials from synthetic and natural molecules for prospective breast cancer nanotherapy;Frontiers in Pharmacology;2023-05-19

5. Cationic lipid-conjugated bis-arylidene oxindole derivatives as broad-spectrum breast cancer-selective therapeutics;Bioorganic Chemistry;2023-04